From the regulatory functions of B cells to the identification of cytokine-producing plasma cell subsets

Current Opinion in Immunology

Volumn 28, Issue 1, 2014, Pages 77-83

  Dang, Van Duc ^a   Hilgenberg, Ellen ^a   Ries, Stefanie ^a   Shen, Ping ^a   Fillatreau, Simon ^a  

^a DEUTSCHES RHEUMA FORSCHUNGSZENTRUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ATACICEPT; B LYMPHOCYTE INDUCED MATURATION PROTEIN 1; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN A; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERFERON REGULATORY FACTOR 4; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 35; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN SPECIFICITY; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CHAGAS DISEASE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE EXACERBATION; HELPER CELL; HOST RESISTANCE; HUMAN; INFECTION RESISTANCE; INNATE IMMUNITY; INTESTINE MUCOSA; MULTIPLE SCLEROSIS; NONHUMAN; PLASMA CELL; REGULATORY T LYMPHOCYTE; REVIEW; SALMONELLOSIS; SEPSIS; TH2 CELL; VIRUS INFECTION;

ANIMALS; B-LYMPHOCYTES; CELL DIFFERENTIATION; CYTOKINES; HUMANS; NITRIC OXIDE SYNTHASE TYPE II; PLASMA CELLS; TRYPANOSOMA CRUZI;

EID: 84896041306     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2014.02.009     Document Type: Review

References (58)

1. Manz R.A., Hauser A.E., Hiepe F., Radbruch A. Maintenance of serum antibody levels. Annu Rev Immunol 2005, 23:367-386.
2. White R.G. Antibody production by single cells. Nature 1958, 182:1383-1384.
3. Helmreich E., Kern M., Eisen H.N. The secretion of antibody by isolated lymph node cells. J Biol Chem 1961, 236:464-473.
4. Fillatreau S., Sweenie C.H., McGeachy M.J., Gray D., Anderton S.M. B cells regulate autoimmunity by provision of IL-10. Nat Immunol 2002, 3:944-950.
5. Barr T.A., Shen P., Brown S., Lampropoulou V., Roch T., Lawrie S., Fan B., O'Connor R.A., Anderton S.M., Bar-Or A., et al. B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells. J Exp Med 2012, 209:1001-1010.
6. Evans J.G., Chavez-Rueda K.A., Eddaoudi A., Meyer-Bahlburg A., Rawlings D.J., Ehrenstein M.R., Mauri C. Novel suppressive function of transitional 2 B cells in experimental arthritis. J Immunol 2007, 178:7868-7878.
7. Yanaba K., Bouaziz J.D., Haas K.M., Poe J.C., Fujimoto M., Tedder T.F. A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity 2008, 28:639-650.
8. Neves P., Lampropoulou V., Calderon-Gomez E., Roch T., Stervbo U., Shen P., Kuhl A.A., Loddenkemper C., Haury M., Nedospasov S.A., et al. Signaling via the MyD88 adaptor protein in B cells suppresses protective immunity during Salmonella typhimurium infection. Immunity 2010, 33:777-790.
9. Teichmann L.L., Kashgarian M., Weaver C.T., Roers A., Muller W., Shlomchik M.J. B cell-derived IL-10 does not regulate spontaneous systemic autoimmunity in MRL. Fas(lpr) mice. J Immunol 2012, 188:678-685.
10. Shen P., Roch T., Lampropoulou V., O'Connor R.A., Stervbo U., Hilgenberg E., Ries S., Dang V.D., Jaimes Y., Daridon C., et al. IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases. Nature 2014, in press. 10.1038/nature12979.
11. Martins G., Calame K. Regulation and functions of Blimp-1 in T and B lymphocytes. Annu Rev Immunol 2008, 26:133-169.
12. Nutt S.L., Heavey B., Rolink A.G., Busslinger M. Commitment to the B-lymphoid lineage depends on the transcription factor Pax5. Nature 1999, 401:556-562.
13. Sciammas R., Shaffer A.L., Schatz J.H., Zhao H., Staudt L.M., Singh H. Graded expression of interferon regulatory factor-4 coordinates isotype switching with plasma cell differentiation. Immunity 2006, 25:225-236.
14. Klein U., Casola S., Cattoretti G., Shen Q., Lia M., Mo T., Ludwig T., Rajewsky K., Dalla-Favera R. Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination. Nat Immunol 2006, 7:773-782.
15. Lee C.G., Kang K.H., So J.S., Kwon H.K., Son J.S., Song M.K., Sahoo A., Yi H.J., Hwang K.C., Matsuyama T., et al. A distal cis-regulatory element, CNS-9, controls NFAT1 and IRF4-mediated IL-10 gene activation in T helper cells. Mol Immunol 2009, 46:613-621.
16. Lee C.G., Hwang W., Maeng K.E., Kwon H.K., So J.S., Sahoo A., Lee S.H., Park Z.Y., Im S.H. IRF4 regulates IL-10 gene expression in CD4(+) T cells through differential nuclear translocation. Cell Immunol 2011, 268:97-104.
17. Ahyi A.N., Chang H.C., Dent A.L., Nutt S.L., Kaplan M.H. IFN regulatory factor 4 regulates the expression of a subset of Th2 cytokines. J Immunol 2009, 183:1598-1606.
18. Cretney E., Xin A., Shi W., Minnich M., Masson F., Miasari M., Belz G.T., Smyth G.K., Busslinger M., Nutt S.L., et al. The transcription factors Blimp-1 and IRF4 jointly control the differentiation and function of effector regulatory T cells. Nat Immunol 2011, 12:304-311.
19. Martins G.A., Cimmino L., Shapiro-Shelef M., Szabolcs M., Herron A., Magnusdottir E., Calame K. Transcriptional repressor Blimp-1 regulates T cell homeostasis and function. Nat Immunol 2006, 7:457-465.
20. Kallies A., Hawkins E.D., Belz G.T., Metcalf D., Hommel M., Corcoran L.M., Hodgkin P.D., Nutt S.L. Transcriptional repressor Blimp-1 is essential for T cell homeostasis and self-tolerance. Nat Immunol 2006, 7:466-474.
21. Rangaswamy U.S., Speck S.H. Murine Gammaherpesvirus M2 protein induction of IRF4 via the NFAT pathway leads to IL-10 expression in B cells. PLoS Pathog 2014, 10:e1003858.
22. Wilson M.S., Taylor M.D., O'Gorman M.T., Balic A., Barr T.A., Filbey K., Anderton S.M., Maizels R.M. Helminth-induced CD19+CD23hi B cells modulate experimental allergic and autoimmune inflammation. Eur J Immunol 2010, 40:1682-1696.
23. Su Y., Zhang A.H., Noben-Trauth N., Scott D.W. B-cell gene therapy for tolerance induction: host but not donor B-cell derived IL-10 is necessary for tolerance. Front Microbiol 2011, 2:154.
24. Lampropoulou V., Hoehlig K., Roch T., Neves P., Calderon Gomez E., Sweenie C.H., Hao Y., Freitas A.A., Steinhoff U., Anderton S.M., et al. TLR-activated B cells suppress T cell-mediated autoimmunity. J Immunol 2008, 180:4763-4773.
25. Devergne O., Birkenbach M., Kieff E. Epstein-Barr virus-induced gene 3 and the p35 subunit of interleukin 12 form a novel heterodimeric hematopoietin. Proc Natl Acad Sci U S A 1997, 94:12041-12046.
26. Collison L.W., Workman C.J., Kuo T.T., Boyd K., Wang Y., Vignali K.M., Cross R., Sehy D., Blumberg R.S., Vignali D.A. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 2007, 450:566-569.
27. Niedbala W., Wei X.Q., Cai B., Hueber A.J., Leung B.P., McInnes I.B., Liew F.Y. IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells. Eur J Immunol 2007, 37:3021-3029.
28. Macpherson A.J., Uhr T. Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science 2004, 303:1662-1665.
29. Fagarasan S., Kawamoto S., Kanagawa O., Suzuki K. Adaptive immune regulation in the gut: T cell-dependent and T cell-independent IgA synthesis. Annu Rev Immunol 2010, 28:243-273.
30. Tezuka H., Abe Y., Iwata M., Takeuchi H., Ishikawa H., Matsushita M., Shiohara T., Akira S., Ohteki T. Regulation of IgA production by naturally occurring TNF/iNOS-producing dendritic cells. Nature 2007, 448:929-933.
31. Fritz J.H., Rojas O.L., Simard N., McCarthy D.D., Hapfelmeier S., Rubino S., Robertson S.J., Larijani M., Gosselin J., Ivanov I.I., et al. Acquisition of a multifunctional IgA+ plasma cell phenotype in the gut. Nature 2012, 481:199-203.
32. Teichmann L.L., Ols M.L., Kashgarian M., Reizis B., Kaplan D.H., Shlomchik M.J. Dendritic cells in lupus are not required for activation of T and B cells but promote their expansion, resulting in tissue damage. Immunity 2010, 33:967-978.
33. Suzuki K., Meek B., Doi Y., Muramatsu M., Chiba T., Honjo T., Fagarasan S. Aberrant expansion of segmented filamentous bacteria in IgA-deficient gut. Proc Natl Acad Sci U S A 2004, 101:1981-1986.
34. Maaser C., Housley M.P., Iimura M., Smith J.R., Vallance B.A., Finlay B.B., Schreiber J.R., Varki N.M., Kagnoff M.F., Eckmann L. Clearance of Citrobacter rodentium requires B cells but not secretory immunoglobulin A (IgA) or IgM antibodies. Infect Immun 2004, 72:3315-3324.
35. Minoprio P., Andrade L., Lembezat M.P., Ozaki L.S., Coutinho A. Indiscriminate representation of VH-gene families in the murine B lymphocyte responses to Trypanosoma cruzi. J Immunol 1989, 142:4017-4021.
36. Bermejo D.A., Amezcua Vesely M.C., Khan M., Acosta Rodriguez E.V., Montes C.L., Merino M.C., Toellner K.M., Mohr E., Taylor D., Cunningham A.F., et al. Trypanosoma cruzi infection induces a massive extrafollicular and follicular splenic B-cell response which is a high source of non-parasite-specific antibodies. Immunology 2011, 132:123-133.
37. Minoprio P., Burlen O., Pereira P., Guilbert B., Andrade L., Hontebeyrie-Joskowicz M., Coutinho A. Most B cells in acute Trypanosoma cruzi infection lack parasite specificity. Scand J Immunol 1988, 28:553-561.
38. d'Imperio Lima M.R., Eisen H., Minoprio P., Joskowicz M., Coutinho A. Persistence of polyclonal B cell activation with undetectable parasitemia in late stages of experimental Chagas' disease. J Immunol 1986, 137:353-356.
39. Reina-San-Martin B., Cosson A., Minoprio P. Lymphocyte polyclonal activation: a pitfall for vaccine design against infectious agents. Parasitol Today 2000, 16:62-67.
40. Miyazaki Y., Hamano S., Wang S., Shimanoe Y., Iwakura Y., Yoshida H. IL-17 is necessary for host protection against acute-phase Trypanosoma cruzi infection. J Immunol 2010, 185:1150-1157.
41. Schulz S.M., Kohler G., Holscher C., Iwakura Y., Alber G. IL-17A is produced by Th17, gammadelta T cells and other CD4- lymphocytes during infection with Salmonella enterica serovar Enteritidis and has a mild effect in bacterial clearance. Int Immunol 2008, 20:1129-1138.
42. Bermejo D.A., Jackson S.W., Gorosito-Serran M., Acosta-Rodriguez E.V., Amezcua-Vesely M.C., Sather B.D., Singh A.K., Khim S., Mucci J., Liggitt D., et al. Trypanosoma cruzi trans-sialidase initiates a program independent of the transcription factors RORgammat and Ahr that leads to IL-17 production by activated B cells. Nat Immunol 2013, 14:514-522.
43. Brustle A., Heink S., Huber M., Rosenplanter C., Stadelmann C., Yu P., Arpaia E., Mak T.W., Kamradt T., Lohoff M. The development of inflammatory T(H)-17 cells requires interferon-regulatory factor 4. Nat Immunol 2007, 8:958-966.
44. Huber M., Brustle A., Reinhard K., Guralnik A., Walter G., Mahiny A., von Low E., Lohoff M. IRF4 is essential for IL-21-mediated induction, amplification, and stabilization of the Th17 phenotype. Proc Natl Acad Sci U S A 2008, 105:20846-20851.
45. Martin G.S., Mannino D.M., Eaton S., Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003, 348:1546-1554.
46. Beutler B., Milsark I.W., Cerami A.C. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 1985, 229:869-871.
47. Hotchkiss R.S., Coopersmith C.M., McDunn J.E., Ferguson T.A. The sepsis seesaw: tilting toward immunosuppression. Nat Med 2009, 15:496-497.
48. Kelly-Scumpia K.M., Scumpia P.O., Weinstein J.S., Delano M.J., Cuenca A.G., Nacionales D.C., Wynn J.L., Lee P.Y., Kumagai Y., Efron P.A., et al. B cells enhance early innate immune responses during bacterial sepsis. J Exp Med 2011, 208:1673-1682.
49. Rauch P.J., Chudnovskiy A., Robbins C.S., Weber G.F., Etzrodt M., Hilgendorf I., Tiglao E., Figueiredo J.L., Iwamoto Y., Theurl I., et al. Innate response activator B cells protect against microbial sepsis. Science 2012, 335:597-601.
50. Fillatreau S., Anderton S.M. B-cell function in CNS inflammatory demyelinating disease: a complexity of roles and a wealth of possibilities. Expert Rev Clin Immunol 2007, 3:565-578.
51. Reiber H., Ungefehr S., Jacobi C. The intrathecal, polyspecific and oligoclonal immune response in multiple sclerosis. Mult Scler 1998, 4:111-117.
52. Mahevas M., Patin P., Huetz F., Descatoire M., Cagnard N., Bole-Feysot C., Le Gallou S., Khellaf M., Fain O., Boutboul D., et al. B cell depletion in immune thrombocytopenia reveals splenic long-lived plasma cells. J Clin Invest 2013, 123:432-442.
53. Balazs M., Martin F., Zhou T., Kearney J. Blood dendritic cells interact with splenic marginal zone B cells to initiate T-independent immune responses. Immunity 2002, 17:341-352.
54. O'Connor B.P., Raman V.S., Erickson L.D., Cook W.J., Weaver L.K., Ahonen C., Lin L.L., Mantchev G.T., Bram R.J., Noelle R.J. BCMA is essential for the survival of long-lived bone marrow plasma cells. J Exp Med 2004, 199:91-98.
55. Hartung H.P., Kieseier B.C. Atacicept: targeting B cells in multiple sclerosis. Ther Adv Neurol Disord 2010, 3:205-216.
56. Liang X., Collins C.M., Mendel J.B., Iwakoshi N.N., Speck S.H. Gammaherpesvirus-driven plasma cell differentiation regulates virus reactivation from latently infected B lymphocytes. PLoS Pathog 2009, 5:e1000677.
57. Zheng Y., Chaudhry A., Kas A., deRoos P., Kim J.M., Chu T.T., Corcoran L., Treuting P., Klein U., Rudensky A.Y. Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses. Nature 2009, 458:351-356.
58. Tokoyoda K., Zehentmeier S., Chang H.D., Radbruch A. Organization and maintenance of immunological memory by stroma niches. Eur J Immunol 2009, 39:2095-2099.